More than 15,000 attendees from all over the world will take part in the 20th EULAR Congress from 14 to 17 June
In the wake of the success of the event in 2013, once again, the European League Against Rheumatism Congress (EULAR) has chosen Madrid to host its Congress. The 20th Rheumatism Congress, an important global event for this medical speciality, will take place from 14 to 17 June at IFEMA, attracting more than 15,000 participants from around the world, with a significant impact on the city of Madrid.
EULAR 2017 will cover a wide range of subjects, particularly clinical and scientific innovations in rheumatism. Through different meetings and sessions, the Congress will facilitate meetings and interaction among doctors, scientists, and people with arthritis/rheumatism, health professionals in rheumatology and representatives of the pharmaceutical industry from around the world, creating opportunities for patients to share information and experiences with prestigious speakers. The Congress’ core activity will revolve around poster presentations and exchanges among participants.
All this content will make EULAR a highly innovative and informative forum for clinical research into different facets of this area of medicine. Additionally, delegates will see the results of new initiatives related to the EULAR School of Rheumatology, the EULAR Campaign and the EULAR Research “RheumaMap” Road Map. The Congress will also host the EMEUNET EULAR, a meeting for young rheumatologists from all over the world, spreading the message that rheumatology is one of the most advanced, successful disciplines of medicine.
The European EULAR League is accepted as the main platform for sharing scientific and clinical information about different aspects of the illness, through the many areas of research covered by this international association. The main objectives of this meeting are to educate, inspire and encourage the development and creation of communication channels among medical professionals and international associations.
As well as EULAR, other large international congresses in the medical and scientific sector will take place at IFEMA in the coming months. One of these is ERA-EDTA, the 54th Congress of the European Renal Association - European Dialysis and Transplant Association, which will take place from 3 to 6 June (8,000 attendees); EHA, the 22nd European Haematology Association Congress, from 22-25 June, with 10,000 attendees; the International Dental Federation (FDI) Congress, which will be held for the first time in Madrid from 29 August to 1 September (5,000 attendees), and ESMO 2017, the Oncology Congress organised by the European Society for Medical Oncology (ESMO) in collaboration with the European Association for Cancer Research (EACR), which will take place at IFEMA again from 8 to 12 September, and which is one of the most significant international meetings on advances in cancer (20,000 attendees). As well as these, the 26th EAO Scientific Meeting of the European Association for Osseointegration will take place from 5 to 7 October (4,000 attendees) and the 37th Congress of the Spanish Society of Internal Medicine (SEMI), from 22 to 24 November (1,700 attendees). Looking ahead to 2019, the European Dermatology and Venerology Congress, EADV 2019, will take place in Madrid for the first time from 9 to 13 October, confirming IFEMA’s leading role as a venue for important international medical and scientific congresses.
Opening session and dinner: http://www.congress.eular.org/official_events.cfm
The European League Against Rheumatism (EULAR) is the organisation which represents the patient, health professional and scientific societies of rheumatology of all the European nations. A recognised charity, it is a non-profit scientific and educational association under Swiss law, EULAR seeks to reduce the burden of rheumatic disease for individuals and for society, and to stimulate, promote and support research, prevention, treatment, and rehabilitation of rheumatic diseases.
IFEMA Communication Management
Marta Cacho | 34.91 722 50 94| email@example.com